Moleculin Biotech Inc (NASDAQ:MBRX)
Share Price & News Healthcare

Similar Companies

Symbol Title
IBIO Ibio Inc
AGRX Agile Therapeutics Inc
OPRX OPTIMIZERx Corp
DNA Ginkgo Bioworks Holdings Inc
AKAN Akanda Corp
BODY Beachbody Company Inc
CL Colgate-Palmolive Co
MBIO Mustang Bio Inc
SKIN Beauty Health Co
CRL Charles River Laboratories International Inc

Analyst Recommendation

Profile

Company Overview: Moleculin Biotech, Inc. (NASDAQ: MBRX) is a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumours and viruses.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms and Conditions